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SUMMARY  
  Rheumatoid arthritis is an inflammatory disease of the synovial joints that affects ~1% 
of the human population, with severe distress due to progressive joint inflammation and 
deformation. When addressing the links between specific components of the apoptotic cell 
clearance machinery and human disease, we noted a correlation between single nucleotide 
polymorphisms (SNPs) in ELMO1, DOCK2, and RAC1 genes and rheumatoid arthritis. ELMO1 
is a cytoplasmic adapter protein that associates with DOCK2 and RAC1 to promote cytoskeletal 
reorganization needed for apoptotic cell uptake by phagocytes. We initially hypothesized that, 
since ELMO1 is linked to apoptotic cell clearance, loss of ELMO1 would lead to increased 
inflammation in arthritis. Contrary to the accumulation of apoptotic cells and greater disease 
severity that we predicted, we observed significantly reduced joint inflammation in two models 
of arthritis in mice lacking ELMO1. Using genetic and cell biological approaches in vivo and 
ex vivo, we determined that ELMO1 deficiency significantly reduces neutrophil recruitment to 
inflamed joints, but does not result in general inhibition of inflammatory responses. Through 
proteomic analyses, we find that ELMO1 protein associates with cellular receptors that 
contribute to neutrophil function in arthritis, and regulates C5a and LTB4 receptor-mediated 
activation and early neutrophil recruitment to the joints. Neutrophil-specific transcriptomics 
show that ELMO1 modulates neutrophil-specific gene expression that includes genes with 
known linkages to human arthritis. Finally, neutrophils from the peripheral blood of human 
donors that carry the SNP in ELMO1 associated with arthritis display increased migratory 
capacity, whereas ELMO1 knockdown reduces human neutrophil migration to LTB4. These 
data identify key ‘non-canonical’ roles for engulfment machinery components in arthritis, and 
ELMO1 as an important regulator of specific neutrophil receptors and signaling linked to 
arthritis. 
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INTRODUCTION 
 Rheumatoid arthritis (RA), which affects millions of people worldwide with a huge 
personal ‘quality of life’ cost as well as a significant economic cost, is characterized by chronic 
joint inflammation and progressive destruction of the bone and cartilage, with debilitating 
consequences 1. In human RA and mouse models of arthritis, leukocyte influx into the joint 
synovium is a hallmark of disease, with neutrophils being the most abundant cells found in the 
inflamed tissue 2,3. Activated neutrophils promote chronic inflammation as well as matrix and 
cartilage degradation 3. Although effective therapies for RA have recently been introduced, 
unfortunately they are not effective in a significant fraction of the patients 4. Genome-wide 
association studies (GWAS) have identified many genetic loci associated with RA; however, 
most of them are characterized by the presence of single nucleotide polymorphisms (SNPs) in 
non-coding genetic regions that function in unknown cell types 5. Therefore, a better 
understanding of causative and disease contributing factors is still critically needed. 
 Cell death via apoptosis occurs as a part of homeostasis and during tissue inflammation 6. 
Although apoptotic cells have been detected in the synovial joints of rheumatoid arthritis 
patients 7-9, resistance to apoptosis has also been implied as a contributory factor to chronic 
disease; therefore, substantial consideration is also given to the induction of apoptosis as a 
therapeutic avenue in arthritis 10-12. For evaluation of the potential treatment approaches to 
increase apoptosis of cells in the arthritic joint, one needs to also consider the specific apoptotic 
cell clearance pathways.  
 Apoptotic cells expose 'eat me' signals on their surface that are recognized by specific 
receptors on phagocytes 13-16. Binding of apoptotic cells to the phagocyte recognition receptors 
results in activation of the engulfment machinery, dynamic changes of the actin cytoskeleton, 
and corpse uptake 13-15. Many phagocyte proteins have been implicated in the binding of 
apoptotic cells. They include receptors that bind phosphatidylserine exposed on the apoptotic 
cell surface directly (such as TIM-4 17-19 and BAI1 20) or indirectly, through bridging molecules 
(such as MerTK21), as well as receptors that recognize cell surface modifications or opsonins 
bound to the apoptotic cells such as CD36 22. The reasons for having many different recognition 
modes and the specific signaling pathways downstream of these engulfment receptors are 
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currently unclear and are intensely investigated	23. One of the better characterized cytoplasmic 
signaling relays that functions downstream of multiple apoptotic cell engulfment receptors (in 
both professional and non-professional phagocytes) is the ELMO/DOCK/Rac signaling 
pathway 24. In this mode of signaling, the ELMO/DOCK protein complex acts as a guanine 
nucleotide exchange factor (GEF) to activate the small GTPase Rac, leading to cytoskeletal 
rearrangements needed for engulfment 25. Inefficient clearance of apoptotic cells can result in 
secondary necrosis and exposure of self-antigens to the immune system, and failures in cell 
clearance have been associated with chronic inflammation and development of autoimmunity 
16,26-28.  
 In this work, we examined how components of a specific engulfment pathway may link 
to inflammatory arthritis. Surprisingly, we found that the loss of engulfment signaling protein 
ELMO1 alleviated, rather than enhanced, disease severity in mouse models of arthritis. Through 
a series of in vitro and in vivo studies, we define a role for the ELMO1 signaling pathway in the 
recruitment of neutrophils into inflamed joints. Further, we find that even after onset of arthritis, 
deletion of ELMO1 can be beneficial in attenuating disease severity. Lastly, we identify a novel 
ELMO1-dependent signature in neutrophils via proteomic and transcriptomic approaches, and 
identify a requirement for ELMO1 in signaling downstream of the receptors for arthritis-
associated molecules C5a and LTB4. We also uncover a functional consequence of the arthritis-
associated ELMO1 SNP rs11984075 in human neutrophil migration. Collectively, these data 
identify non-canonical roles for apoptotic cell engulfment components, a novel neutrophil-
specific ELMO1-dependent signaling nexus that controls different aspects of arthritis, and link a 
specific human SNP ELMO1 rs11984075 to enhanced migration of neutrophils. 
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RESULTS 
Engulfment protein ELMO1 is associated with arthritis 
 To test whether specific engulfment machinery components are associated with human 
rheumatoid arthritis, we searched the publicly available databases for single nucleotide 
polymorphisms (SNPs) associated with human rheumatoid arthritis. We found multiple SNP-
Disease associations with human rheumatoid arthritis in ELMO1, as well as in DOCK2 and 
RAC1 genes (see Methods; Fig. 1a and Supplementary Table 1).  In a recent meta-analysis 
looking for common SNPs or gene linkages to both rheumatoid arthritis (RA) and celiac disease 
(CD), a SNP in human ELMO1 (rs11984075) was found to be highly correlative with a pre-
disposition to developing RA 29. Further, in an omics-based approach assessing the methylation 
status of arthritis associated genes, the genetic locus containing Elmo1 was hypo-methylated in 
fibroblast-like synoviocytes (FLS) that line the synovium of the joints 30 31. ELMO1 functions at 
the interface between the phagocytic receptors and their downstream cytoplasmic signaling 
activity leading to corpse internalization. Our initial hypothesis was that, as ELMO1 is linked to 
clearance of apoptotic cells, a process that is generally anti-inflammatory, disruption of ELMO1 
might lead to greater inflammation in the joints.  
 To test whether expression of specific engulfment machinery components might change 
during joint inflammation in mice, we initially analyzed the K/BxN mouse model of 
spontaneous arthritis 32 (Supplementary Fig. 1a). By approximately one month of age, the 
K/BxN mice develop spontaneous and progressive joint disease resembling rheumatoid arthritis, 
including autoantibody production, chronic joint inflammation, and bone erosion 32. We 
analyzed expression of the engulfment receptors Bai1, Bai2, Bai3, Tim4, Mertk and Cd36 as 
well as the cytoplasmic Elmo/Dock/Rac signaling components in the paw extracts of 9-week old 
K/BxN mice by qPCR. Interestingly, in the K/BxN mice, we only found increased transcript 
levels for Elmo1, Rac1 and Rac2, while the expression of engulfment receptors either remained 
unchanged, or was slightly decreased (Fig. 1b and Supplementary Fig. 1b). We noted increased 
expression of ELMO1 protein in immunoblot analysis of paw extracts from mice with 
spontaneous arthritis (consistent with their increased mRNA levels for Elmo1) (Fig. 1c-d). 
Based on this observation and the linkage of ELMO1 SNPs to human rheumatoid arthritis, we 
addressed the role of ELMO1 further.  
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Elmo1-/- mice show reduced arthritis severity in two different arthritis models 
 Transferring serum from arthritic K/BxN mice to healthy mice initiates joint disease that 
mimics features of human arthritis in many strains of mice 33. The K/BxN serum transfer arthritis 
is thought to model the effector phase of human arthritis (‘inflammatory flare-ups’), due to the 
transient nature and strict dependence on the innate immune system. Disease induction is rapid, 
synchronous, and nearly 100% penetrant, with swelling of the paws apparent 1-2 days post 
K/BxN serum injection 33. Elmo1-/- mice are generally healthy when housed under specific 
pathogen free conditions 34,35, and we tested arthritis development in these mice using the serum 
transfer model via two injections (on day 0 and day 2) of the K/BxN serum (Fig. 1e).  Extracts 
from diseased paws of control mice (but not the Elmo1-/- mice) showed increased ELMO1 
protein levels in the joints during arthritis-associated inflammation (Fig. 1f, lanes 1-4). We next 
assessed arthritis in Elmo1-/- mice and their control littermates using paw swelling and other 
disease parameters to assign clinical scores (see Methods) (note: all of the scoring was performed 
by an investigator blinded to the mouse genotypes until the end of the experimental duration). 
While arthritis was readily observed and comparable in wild type and heterozygous Elmo1+/- 
mice, surprisingly, homozygous Elmo1-/- mice showed significantly milder disease (Fig. 1g). At 
disease maximum (day 10 after the first K/BxN serum injection), Elmo1-/- mice had very mild or 
no paw swelling compared to the littermate controls (Fig. 1h). Histology of ankle sections (at 
day 10) revealed severe inflammatory cell infiltration in control littermates that was significantly 
decreased in Elmo1-/- mice (Fig. 1i). These data suggest that the loss of ELMO1 attenuates 
disease severity in the K/BxN serum transfer model of arthritis. The reduction in disease severity 
in Elmo1-/- mice was also observed with a single injection of K/BxN serum and was not sex-
dependent (data not shown). Since two injections of K/BxN serum induced stronger disease 
(attenuated by ELMO1 deficiency), we have used the two-injection regimen in the rest of this 
work. 
 We also tested whether ELMO1 plays a role in another commonly used arthritis model - 
collagen-induced arthritis (CIA), that mimics many features of human rheumatoid arthritis 36,37, 
and includes involvement of both the innate and adaptive arms of immunity. We back-crossed 
Elmo1-/- mice to the DBA/1J strain, in which collagen-induced arthritis is most consistently seen 
38,39, and immunized them with collagen (see Methods) (Fig. 1j). Again, we noted increased 
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ELMO1 protein levels in the paws of control mice with CIA (but not in the Elmo1-/- mice) (Fig. 
1k). While Elmo1+/+DBA mice developed signs of arthritis around day 21, with most mice 
becoming sick by about 40 days following immunization, remarkably, about a quarter of Elmo1-/-
DBA mice displayed no signs of arthritis throughout the duration of the experiment (Fig. 1l and 
Supplementary Fig. 1c, 1e). Moreover, among the mice that did develop arthritis symptoms, 
Elmo1-/-DBA mice had delayed onset and significantly reduced disease severity compared to 
Elmo1+/+DBA and Elmo1+/-DBA mice (Fig. 1m and Supplementary Fig. 1d, 1f). This difference 
persisted through the chronic stages of disease in both sexes (Supplementary Fig. 1c-f).  These 
data collectively suggest that ELMO1 positively regulates disease severity in arthritis. 
ELMO1 function in neutrophils contributes to disease severity in arthritis  
 When we assessed the presence of uncleared apoptotic cells in the arthritic joints, many 
cleaved caspase-3 positive cells could be seen in the inflammatory infiltrates of the control 
littermates (Fig. 2a, left panel and inset). Surprisingly, very few such cells were observed in the 
Elmo1-null mice (Fig. 2a). Since the fewer apoptotic cells could potentially be linked to the 
overall reduced inflammation within the joints of Elmo1-null mice, we focused on the areas of 
inflammation; even then, there were significantly fewer apoptotic cells (Fig. 2a, right panel). 
This reduction in apoptotic cells was not due to compensatory upregulation of the homologues 
Elmo2 and Elmo3 in the Elmo1-/- mice (Supplementary Fig. 1g). During apoptotic cell clearance, 
ELMO1 binds to the cytoplasmic tail of the phosphatidylserine receptor BAI1, and via 
subsequent downstream signaling, promotes corpse engulfment (Supplementary Fig. 1h) 20. 
Interestingly, Bai1-/- mice developed comparable disease to their wild type littermates in K/BxN 
serum induced arthritis model (Supplementary Fig. 1i). These data suggest that the attenuation 
of arthritis seen in Elmo1-/- mice is likely not linked to cell clearance per se.  
 We then took a genetic approach to address the cell type(s) in which ELMO1 function 
was promoting arthritis. Disease development in the K/BxN serum transfer arthritis requires 
cells of the innate immune system 33. Since ELMO1 protein expression was detected in both 
macrophages and neutrophils (Fig. 2b), we generated mice with conditional deletion of ELMO1 
broadly in the myeloid lineage by crossing Elmo1fl/fl mice 34 with LysM-Cre mice, which express 
Cre recombinase under the LysM promoter 40. When injected with K/BxN serum, 
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LysM-Cre/Elmo1fl/fl mice showed significantly attenuated disease (Fig. 2c). Histological 
examination at disease maximum also revealed reduced inflammation in the ankle joints of 
LysM-Cre/Elmo1fl/fl mice (Fig. 2d), and correlated with the loss of ELMO1 protein in myeloid 
lineage cells (Supplementary Fig. 2a). Of note, LysM-Cre expression alone (without floxed 
Elmo1 alleles) does not alter disease development in the K/BxN serum induced arthritis 
(Supplementary Fig. 2b). These data suggest that ELMO1 expression in myeloid cells regulates 
arthritis severity. 
 Analyzing the cellular composition of the inflammatory infiltrate within the paws, fewer 
CD11b+Ly6G+ neutrophils were seen at disease maximum in the global Elmo1-/- mice, as well as 
the LysM-Cre/Elmo1fl/f mice (Fig. 2e, Supplementary Fig. 2c-d). This indicated a possible link 
between ELMO1 expression and neutrophil infiltration into the inflamed synovial tissue. To test 
the importance of ELMO1 expression in neutrophils versus macrophage/monocytic lineages, we 
crossed Elmo1fl/fl mice with either MRP8-Cre mice to delete Elmo1 expression primarily in 
neutrophils 41, or CX3CR1-Cre mice, which primarily targets monocytes/macrophages 42,43. 
Interestingly, CX3CR1-Cre/Elmo1fl/fl mice developed disease comparable to wild type 
littermates after K/BxN serum injection (Fig. 2f and Supplementary Fig. 2e-f), despite 
decreased ELMO1 protein levels in the macrophage lineage (Fig. 2g). On the other hand, 
deletion of Elmo1 in neutrophils in the MRP8-Cre/Elmo1fl/fl mice led to reduced disease (Fig. 2h 
and Supplementary Fig. 2g). Histological examination of ankle joints showed reduced 
inflammatory cell infiltration in MRP8-Cre/Elmo1fl/fl mice (Fig. 2i). ELMO1 deficiency in 
neutrophils from MRP8-Cre/Elmo1fl/fl mice was verified by immunoblot analysis of purified 
Ly6G+ cells (Supplementary Fig. 2h). Thus, reduced arthritis induction in MRP8-Cre/Elmo1fl/fl 
mice phenocopies the global Elmo1-null mice (Fig. 2h and 1g). Importantly, Cre expression 
alone (via MRP8 promoter in neutrophils) does not reduce disease severity (Supplementary Fig. 
2i and data not shown). Since ELMO1 expression was previously reported in fibroblast-like 
synoviocytes (FLS) 30, we considered the possibility that MRP8-Cre/Elmo1fl/fl mice might have 
affected these cells. However, even in control mice, ELMO1 protein was barely detectable in 
the FLS (compared to the strong expression in neutrophils that is lost in MRP8-Cre/Elmo1fl/fl 
cells) (Supplementary Fig. 2j). Thus, the attenuated disease in MRP8-Cre/Elmo1fl/fl mice during 
K/BxN serum induced arthritis appears to be due to the loss of ELMO1 function in neutrophils.  
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 To address whether ELMO1 may function as a broad inhibitor of inflammation, we used 
several models of inflammation associated with neutrophil infiltration. First, we challenged 
Elmo1+/+ and Elmo1-/- mice with intranasal administration of LPS and monitored the recruitment 
of neutrophils to the lung (Supplementary Fig. 3a). Eight hours post-LPS administration, 
significant recruitment of neutrophils was detected in the bronchoalveolar lavage of control 
mice, and this was not significantly altered in Elmo1-/- mice (Supplementary Fig. 3b). Second, 
we tested whether mice with ELMO1 deficiency can combat a severe bacterial infection in vivo. 
We subjected Elmo1+/+ and Elmo1-/- mice to fecal-induced peritonitis (FIP), a model of septic 
shock44,45, and assessed neutrophil recruitment into the infected peritoneum, as well as clinical 
parameters of disease development and survival (Supplementary Fig. 3c). Four hours after FIP 
induction, Elmo1-/- mice had comparable neutrophil infiltration as control mice to the site of 
infection (Supplementary Fig. 3d). The transient temperature drop and clinical scores also did 
not differ between Elmo1+/+ and Elmo1-/- mice (Supplementary Fig. 3e-f). Furthermore, the 
survival of Elmo1-/- mice was not different compared to control mice (Supplementary Fig. 3g). 
We also directly tested purified Elmo1-/- neutrophils in their ability to kill a bacterial pathogen 
Klebsiella pneumoniae, clearance of which potently depends on neutrophil function 46. Again, 
Elmo1-/- neutrophils were not impaired in in vitro killing of Klebsiella pneumoniae 
(Supplementary Fig. 3h).  Third, as Elmo1-/- mice do not exhibit symptoms associated with 
autoimmunity when housed under specific pathogen free conditions, we tested these mice in 
experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis 47,48 that 
involves adaptive immunity and neutrophil function 49. Elmo1-/- mice developed EAE symptoms 
comparable to control animals, and had similar levels of demyelination (Supplementary Fig. 3i-j 
and data not shown). Collectively, these data suggest that ELMO1 deficiency does not generally 
impair inflammation, and that there is likely a specificity associated with ELMO1 loss in 
neutrophils and attenuation of arthritis signs.  
ELMO1 regulates neutrophil chemotaxis to inflamed joints 
 To better understand the differences in arthritis severity due to ELMO1 deletion in 
neutrophils versus macrophages, and to help decipher how ELMO1 might affect neutrophil 
function during arthritis, we assessed the ELMO1 protein interactome in neutrophils versus 
macrophages. We purified Ly6G+ neutrophils from the bone marrow and resident peritoneal 
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macrophages from Elmo1+/+ and Elmo1-/- mice, and performed ELMO1 immunoprecipitation, 
followed by liquid chromatography mass spectrometry (LC-MS) and proteomics analysis (Fig. 
3a). Comparison of the proteomics results between Elmo1+/+ and Elmo1-/- mice helped identify 
ELMO1-specific protein partners (either direct or indirect interaction with ELMO1). Further 
analysis of ELMO1 protein interactomes in neutrophils versus macrophages (see Methods), 
helped identify the neutrophil-specific ELMO1 protein interaction network composed of 30 
proteins (Fig. 3b and Supplementary Table 2). Neutrophil-specific ELMO1 protein interactome 
was analyzed by STRING (string-db.org) to reveal protein-protein interactions	 50. The known 
ELMO1 partners DOCK and RAC were added to Fig. 3b to provide context (highlighted in 
blue), although DOCK and RAC were found in interactomes of both neutrophils and 
macrophages. The newly identified neutrophil-specific ELMO1 partners have a range of distinct 
functions 51-67, and several have known associations with human arthritis (Fig. 3c) 68-77. 
 Interestingly, several of the neutrophil-specific ELMO1 protein partners are linked to the 
regulation of cell migration (Fig. 3b-c), Initial neutrophil recruitment into the synovium during 
arthritis is mediated by leukotriene B4 (LTB4) and further sustained by CXCR2 agonists such 
as CXCL1 78,79. As ELMO1 has also been linked to gradient dependent migration 80-83, we 
examined migration of purified neutrophils from WT and ELMO1-deficient mice in a Transwell 
migration assay. Elmo1-/- neutrophils showed significantly reduced migration toward LTB4 and 
CXCL1 (Fig. 3d). This reduced migration was not a purification related phenomenon, as 
reduced migration of Elmo1-deficient neutrophils toward LTB4 and CXCL1 was also seen 
when total bone marrow cells were used (Supplementary Fig. 4a). To visualize the linkage 
between ELMO1 expression and neutrophil migration in vivo, we used two-photon microscopy 
to analyze neutrophil swarming towards the site of laser-induced injury in the mouse ear (which 
is also LTB4-dependent 84). Compared to wild type neutrophils showing increased and directed 
migration toward the site of injury, Elmo1-/- neutrophils did not effectively move to the injury 
site and did not increase the speed of movement (Fig. 3e-f and Movie S1).  
 Since neutrophil migration into the joint synovium is a hallmark of acute inflammatory 
episodes in human rheumatoid arthritis, and is also a requirement for disease development in the 
K/BxN serum induced arthritis model 3,85,86, we asked whether ELMO1 might affect neutrophil 
migration to the joints. Elmo1+/- and Elmo1-/- mice were injected with K/BxN serum, and 
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neutrophil infiltration into the joints was imaged via IVIS scanning after 24hr by the 
luminescent signal that arises from the myeloperoxidase-mediated conversion of injected 
luminol 87,88. Compared to control animals, Elmo1-/- mice had much reduced luminescence in the 
joints after K/BxN serum injection (Fig. 4a). Reduced migration of Elmo1-deficient neutrophils 
was not due to altered expression of the receptors for the chemokines LTB4 or CXCL1, as 
Elmo1-/- neutrophils expressed comparable levels of the LTB4 receptor (Blt1) transcript to those 
observed in Elmo1+/+ cells (Supplementary Fig. 4b), and the protein levels of the CXCL1 
receptor CXCR2 were unchanged on the surface of neutrophils in both blood and bone marrow 
(Supplementary Fig. 4c).  
ELMO1 acts as a relay between chemokine receptors and neutrophil activation/migration  
 The above data demonstrated that ELMO1 regulates neutrophil migration in vitro and 
in vivo, and in response to chemokines linked to arthritis. As neutrophil migration to other 
inflammatory stimuli (such as LPS stimulation, or bacterial infection) was not affected by loss 
of ELMO1, one possible mechanistic explanation was that ELMO1 might function downstream 
of receptor(s) for arthritis-linked chemokines. Therefore, we mined our proteomics data for 
potential ELMO1 associated membrane proteins linked to arthritis (Fig. 3b-c).  We identified 
two novel ELMO1-binding membrane proteins, both of which have been previously linked to 
human neutrophil activation/migration to inflamed joints - C5aR1/CD88, receptor for the 
complement component C5a (also called anaphylatoxin), and the integrin CD11b/Itgam 
(Fig. 3b, highlighted in yellow)72,89-92.  
 C5a/C5aR1 is referred to as a “master switch” in neutrophil recruitment that drives 
establishment of clinical signs of disease in arthritis	86,93,94. Of note, C5a/C5aR1 signaling does 
not appear to regulate disease phenotypes in EAE or LPS challenge models	95-97, which we also 
found are not influenced by ELMO1 deficiency (Supplementary Fig. 3). In arthritis, C5aR1 
ligation is uniquely required for initial neutrophil adhesion to the endothelium and firm arrest, 
and is mediated via upregulation of integrins on the neutrophil surface, such as CD11b (our 
second ELMO1 binding partner of interest)	 98. CD11b is also a classic neutrophil activation 
marker that is upregulated by different stimuli to regulate migration, including during LTB4-
dependent neutrophil swarming 84. Therefore, we next asked whether CD11b cell surface 
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exposure induced by neutrophil activation with C5a or LTB4 would be altered due to ELMO1 
deficiency (Fig. 4b). CD11b levels on wild type neutrophils were strongly increased by C5a or 
LTB4 stimulation (Fig. 4c-d), and this was significantly stunted in Elmo1-/- neutrophils (Fig. 
4d), suggesting that ELMO1 may function in a signaling relay (i.e. inside-out signaling) 
between neutrophil activation and CD11b integrin-mediated cell adhesion. As control, we did 
not observe differences in LTB4 or C5a receptor expression, or ligand-dependent C5aR1 
internalization in Elmo1-/- neutrophils (Fig. 4e). We then asked whether CD11b is required for 
neutrophil migration in response to LTB4. Blocking CD11b function with a neutralizing 
antibody reduced neutrophil migration to the levels observed in Elmo1-/- cells (Fig. 4f), 
suggesting that ELMO1 regulation of neutrophil migration to LTB4 is in part dependent on 
CD11b. ELMO1-deficient neutrophils were not inherently deficient in CD11b upregulation, as 
bypassing receptor-mediated activation by a strong intracellular stimulus such as PMA resulted 
in comparable CD11b increase between Elmo1+/+ and Elmo1-/- neutrophils (Fig. 4g, left panel).  
 We also tested the specificity of ELMO1 for CD11b upregulation/migration in response 
to arthritis-associated chemokines LTB4 and C5a versus other stimuli. We observed a poor 
induction of CD11b levels by bacterially derived LPS in neutrophil sufficient or deficient for 
ELMO1, even upon exposure to a high concentration of LPS (Fig. 4g, right panel). We also 
examined CD11b induction with aggregated IgG (to mimic immune complexes), and found that 
CD11b was comparably upregulated in WT and Elmo1-/- neutrophils (Fig. 4h). Furthermore, 
immune complex mediated neutrophil degranulation and release of chemotactic factors was also 
not impaired by ELMO1 deficiency, as determined by migration of wild type neutrophils to the 
chemotactic mediators present in the supernatants from IgG-activated Elmo1-/- neutrophils (Fig. 
4i). It is worth noting that we found no alterations in the surface levels of neutrophil receptors 
FcgRIII and FcgRIV 88,93,99, or the protein tyrosine kinase Syk that is required for Fcg receptor 
signaling	 100, in Elmo1-/- neutrophils from blood and bone marrow (Supplementary Fig. 4d-f). 
Collectively, these data suggest that ELMO1 is part of the signaling relay that occurs between 
specific arthritis-associated chemokines (such as C5a and LTB4) and the neutrophil activation 
marker CD11b linked to neutrophil migration. 
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Induced deletion of Elmo1 after disease onset reduces arthritis severity  
 To test whether deletion of Elmo1 after induction of arthritis can alleviate disease 
parameters, we crossed Elmo1fl/fl mice with Ubc-CreERt2 mice, in which the Cre-recombinase is 
expressed ubiquitously; however, the ERt2-Cre stays functionally inactive due to its fusion with 
an ER-domain until the administration of tamoxifen, which induces activation of Cre, and this 
can be done in adult mice at the desired time 101.  After verifying that Elmo1 deletion in Ubc-
CreERt2/Elmo1fl/fl mice does not occur prior to the administration of tamoxifen (data not shown), 
we first induced arthritis in Ubc-CreERt2/Elmo1fl/fl and littermate controls by injection of K/BxN 
serum on days 0 and 2 (Fig. 4j). Starting on day 3, we administered tamoxifen (see Methods) to 
induce Elmo1 deletion, and monitored disease parameters. Tamoxifen administration in arthritic 
Ubc-CreERt2/Elmo1fl/fl mice resulted in the rapid arrest of further disease development and 
enhanced recovery in both sexes (Fig. 4k and Supplementary Fig. 5a), compared to tamoxifen-
treated littermate control mice. Since only a partial loss of ELMO1 protein expression was 
observed in peritoneal and bone marrow cells from Ubc-CreERt2/Elmo1fl/fl mice (Fig. 4l), this 
suggests that even partial reduction in ELMO1 during acute phases of arthritis could be of 
benefit. Importantly, Ubc-CreERt2/Elmo1fl/fl mice did not have reduced disease if tamoxifen was 
not administered and deletion of Elmo1 was not induced (Supplementary Fig. 5b).  
 To further test the hypothesis that ELMO1 contributes to the early recruitment of 
neutrophils to the joint, we deleted Elmo1 during the peak of K/BxN serum induced arthritis, 
after the neutrophil mobilization has already occurred (Supplementary Fig. 5c). When induced 
by this “late” regimen, loss of ELMO1 did not significantly improve signs of disease 
(Supplementary Fig. 5d), suggesting that ELMO1 function contributes to the early stages of 
disease development in this model of arthritis. 
Elmo1 regulates cell type-specific transcriptional programs 
 Since Rac1, which functions downstream of ELMO1, has been shown to regulate gene 
transcription, we next asked if ELMO1 regulates transcriptional networks by RNA-seq analysis. 
In addition to comparing the gene expression of cells with or without ELMO1, we compared the 
transcriptomes of neutrophils and macrophages to identify neutrophil-specific ELMO1-
dependent transcriptional signatures (Fig. 5a). In both cell types, modulators of actin 
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cytoskeleton dynamics and cell adhesion/migration were regulated by Elmo1 (Supplementary 
Table 3). However, we noted a clear difference in the prominent classes of functionally related 
transcripts between the two cell types analyzed. There was an overall paucity of shared genes 
and transcriptional programs regulated by Elmo1, suggesting a previously unappreciated cellular 
specificity in Elmo1-dependent gene networks. Elmo1-regulated transcriptomes in neutrophils 
and macrophages overlapped in only ten genes (including Elmo1 itself) (Fig. 5b and 
Supplementary Table 3). Remarkably, we find that Elmo1 deficiency in neutrophils associates 
with decreased expression of arthritis-promoting factors and increased expression of protective 
modulators (Fig. 5c-d), with many of the Elmo1-dependent neutrophil-specific genes having 
been previously linked to arthritis disease progression 102-114 (Fig. 5b-d). Moreover, neutrophils 
lacking ELMO1 exhibited an anti-inflammatory signature (Fig. 5b and Supplementary Table 3), 
exemplified by the marked up-regulation of the gene Tnfaip1, which encodes A20, a potent 
inhibitor of NFkB signaling, whose loss in myeloid cells has been shown to lead to the 
development of spontaneous arthritis in mice 115 116.  
ELMO1 SNP rs11984075 alters neutrophil migration 
 When we took a closer look at the ELMO1 locus for SNP-disease associations, we found 
multiple SNPs correlating with diabetic nephropathy, IgG glycosylation, celiac disease, and 
psoriasis, in addition to rheumatoid arthritis (Fig. 6a). Although none of the RA-associated 
SNPs in ELMO1 have been reported to cause changes in mRNA or protein expression, Elmo1 
expression levels were altered in a mouse model of diabetic nephropathy 117. ELMO1 protein 
expression is readily detected in human peripheral blood neutrophils (Supplementary Fig. 5e). 
To examine whether the presence of rheumatoid arthritis-associated SNPs in ELMO1 may alter 
ELMO1 protein levels and neutrophil functions, we screened genomic material from 15 healthy 
blood donors for the presence of ELMO1 rs11984075 and ELMO1 rs10488029 (see 
Supplementary Table 1). Two of the fifteen donors were heterozygous for the ELMO1 
rs11984075 (Fig. 6b), whereas none bore ELMO1 rs10488029 (data not shown). ELMO1 
protein expression in neutrophils from the two ELMO1 rs11984075 donors was elevated ~20% 
when compared to wild type cells (Fig. 6c), suggesting the possibility that this intronic mutation 
could have additional effects on gene expression 118. Remarkably, neutrophils from the two 
ELMO1 rs11984075 donors displayed increased migration toward LTB4 in a Transwell assay 
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(Fig. 6d) and had elevated levels of L-selectin/CD62L, a leukocyte receptor that mediates early 
stages of adhesion to the vascular endothelium during neutrophil extravasation and contributes 
to disease development in mouse models of arthritis 119,120  (Fig. 6e). This was particularly 
interesting, as we also found significantly reduced levels of CD62L on the surface of circulating 
neutrophils in Elmo1-/- mice (Fig. 6f), suggesting an additional putative avenue for ELMO1 
regulation of neutrophil recruitment. Since the bone marrow neutrophils from Elmo1-/- mice had 
comparable levels of CD62L (Fig. 6g), loss of ELMO1 likely regulates this adhesion molecule 
in fully matured neutrophils.  
 As a complement to this set of observations suggesting a ‘gain of function’ with 
rs11984075, we tested whether the loss of ELMO1 in human neutrophils affected their 
migration to arthritis-associated chemokines. Since ELMO1 depletion in primary human 
neutrophils is not feasible (due to their short life span), we utilized the human neutrophil cell 
line HL-60 121 to analyze whether loss of ELMO1 in human neutrophils would inhibit 
chemotaxis. HL-60 cells with shRNA mediated knockdown of ELMO1 expression (Fig. 6h) 
were differentiated into neutrophils (as per 122) exhibited reduced migration to LTB4 compared 
to control shRNA expressing cells (Fig. 6i). Collectively, these observations demonstrate that 
ELMO1 modulates human neutrophil chemotaxis to soluble mediators linked to arthritis, 
suggests that the ELMO1 rs11984075 mutation may contribute to enhanced neutrophil 
recruitment to sites of inflammation, and might explain the potential association of this SNP 
with rheumatoid arthritis. 
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DISCUSSION 
Identification of ELMO1 as a multi-pronged contributory factor for arthritis 
Rheumatoid arthritis affects 1% of the human population. While the recent emergence of 
biologics targeting specific inflammatory components have clearly revolutionized the control of 
disease symptoms, they have been effective in only a fraction of patients 4. Thus, this work 
identifying the ELMO1-dependent molecular signaling nexus with linkages to human arthritis 
may provide additional new targets for therapeutic intervention. The combination of tissue 
specific mouse knockout studies, identification of ELMO1 protein interactome, and 
transcriptomic analyses revealed that ELMO1 serves an important signaling nexus in 
neutrophils. Moreover, many of the genes/proteins regulated in an ELMO1-dependent manner 
are genetically linked to human arthritis (via SNPs, altered expression, or biomarker status), or 
functionally linked to experimental arthritis in animal models. Specifically, we identify an 
ELMO1-dependent signature in neutrophils via unbiased approaches, and uncover a novel 
requirement for ELMO1 in the inside-out signaling downstream of the receptors for arthritis-
associated molecules C5a and LTB4, involving regulation of the surface expression of CD11b, 
another key modifier of neutrophil migration to inflamed tissues.  
Since K/BxN serum induced arthritis primarily depends on the innate immune system 
(mimicking the inflammatory flare-ups associated with arthritis), and the CIA depends on both 
the innate and adaptive immunity arms 123, ELMO1 appears to contribute to arthritis progression 
in both acute and chronic phases of the disease. Our discovery of enhanced expression of 
ELMO1 protein in human neutrophils from humans carrying the SNP ELMO1 rs11984075 and 
the higher migration of these neutrophils to the chemokine LTB4, which has been linked to 
early recruitment of neutrophils to the joints, further imply a key linkage of SNPs in ELMO1 to 
human arthritis at a functional and genetic level. Consistent with the diminished migration of 
human neutrophils lacking ELMO1 to LTB4, and the observation in mice that deletion of 
ELMO1 after arthritis initiation could dampen disease symptoms, suggest that targeting 
ELMO1 function in human arthritis may be an avenue to explore in future studies. Since our 
data suggest that ELMO1 deficiency does not impair the neutrophil response to bacterial 
challenge, such approaches may not suppress the immune system indiscriminately.  
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Rethinking the engulfment machinery in the initiation and resolution of inflammation 
A significant amount of data (from many laboratories, including ours) suggest that the 
apoptotic cell clearance process is generally anti-inflammatory. Therefore, when we initially 
noticed SNPs and disease associations of ELMO/DOCK/Rac module with rheumatoid arthritis, 
we hypothesized that this is because of failed apoptotic cell clearance in the arthritic joints (due 
to the absence of this signaling module). However, unexpectedly and strikingly, the data 
accumulated through this work (e.g. the SNP ELMO1 rs11984075 and the mouse knockout 
studies identifying ELMO1 function in neutrophil migration) advance a concept that 
evolutionarily conserved apoptotic cell engulfment machinery components can have both 
canonical and non-canonical roles in inflammation and in different cell types 124-126. Since 
induction of apoptosis in rheumatoid tissues has been proposed as a potential therapeutic 
approach 10-12, our data suggest that careful examination of apoptotic cell engulfment machinery 
components required for the removal of apoptotic cells should also be characterized in specific 
inflammatory contexts. 
Defining shared and unique gene signatures in neutrophils and macrophages 
In comparing the transcriptomics of neutrophils and macrophages from ELMO1 
sufficient and deficient conditions, we had a few surprises. First, there were many genes that 
were uniquely altered by the absence of ELMO1 in neutrophils and macrophages. Second, there 
were only ten core genes that were commonly regulated in both cell types. This is in contrast to 
the ‘general assumption’ that the same genes/proteins likely perform similar functions in 
different cell types, especially among cell types that are of the general myeloid lineage. Since 
many of the unique genes in neutrophils are independently linked to rheumatoid arthritis, these 
data suggest an interesting notion that targeting common pathways could be a less explored area 
with potential benefit in specific instances.  
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METHODS 
Mice 
C57BL/6J, DBA/1J, NOD, MRP8-Cre, CX3CR1-Cre, LysM-Cre, and Ubc-CreERt2 mice were 
obtained from Jackson Laboratories. Elmo1fl/fl and Elmo1-/- mice have been described previously 
34.  To generate mice with deletion of Elmo1 in myeloid cells, neutrophils or macrophages, 
Elmo1fl/fl mice were crossed to LysM-Cre, MRP8-Cre or CX3CR1-Cre mice, respectively. To 
generate mice with inducible deletion of Elmo1, Elmo1fl/fl mice were crossed to Ubc-CreERt2. In 
these mice, Elmo1 deletion was induced by three daily intraperitoneal injections of 40 mg/kg 
tamoxifen dissolved in corn oil. To generate Elmo1-/-DBA mice, Elmo1-/- mice were backcrossed 
onto the DBA/1J background for at least 5 generations. KRN TCR transgenic mice 32 were a gift 
from Dr. Diane Mathis at the Harvard Medical School, and were bred to NOD mice to obtain the 
K/BxN mice 33, which develop progressive spontaneous arthritis. K/BxN serum was collected 
from 9-week old K/BxN mice by cardiac puncture. Age- and sex-matched littermate control 
animals were used for all experiments, and both males and females were assessed. In LysM-
Cre/Elmo1fl/fl mice, reduced disease severity was observed in female, but not in male mice (data 
not shown). All animal procedures were approved by and performed according to guidelines of 
the Institutional Animal Care and Use Committee (IACUC) at the University of Virginia.  
K/BxN serum transfer induced arthritis 
Mice were injected with 150 µl of serum from K/BxN mice on day 0 (one dose K/BxN) or on
days 0 and 2 (two dose K/BxN). In experiments with inducible deletion of Elmo1, tamoxifen was 
administered on days 3, 4 and 5. Paw swelling was measured at indicated time points using a 
caliper (Fisher). Clinical scores were assigned for each paw as follows: 0 – no paw swelling or 
redness observed, 1 – redness of the paw or a single digit swollen, normal V shape of the hind 
foot (the foot at the base of the toes is wider than the heel and ankle) 2 – two or more digits 
swollen or visible swelling of the paw, U shape of the hind foot (the ankle and the midfoot are 
equal in thickness), 3 – reversal of the V shape of the hind foot into an hourglass shape (the foot 
is wider at the heel than at the base of the toes). A combined clinical score of all paws is 
presented. Scores were assigned by an investigator blinded to the mouse genotypes. Pictures 
were taken with the Nikon Lumix camera. 
Collagen induced arthritis (CIA) 
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Elmo1-/- mice in the DBA background were immunized at the base of the tail by intradermal 
injection of a 1:1 solution of 10 mM acetic acid containing 100 µg of bovine collagen-II and
Complete Freund’s Adjuvant (Sigma) containing 100 µg of heat killed Mycobacterium
tuberculosis H37Ra (BD). Mice received a booster immunization on day 21. Paw swelling was 
measured at indicated time points using a caliper. Clinical scores were assigned for each paw as 
follows: 0 – no paw swelling or redness observed, 1 – redness of the paw or a single digit 
swollen, 2 – two or more digits swollen or visible swelling of the paw, 3 – visible swelling of the 
ankle, 4 – ankylosis of the joint. A combined clinical score of all paws is presented. Scores were 
assigned by an investigator blinded to the mouse genotypes. 
Experimental autoimmune encephalomyelitis (EAE) 
EAE was induced in female mice (8 to 12 weeks) by subcutaneous injection of MOG35-55 peptide 
(100 µg, CSBio) emulsified in complete Freund’s adjuvant. Pertussis toxin (250 ng, List
Biologicals) was administered i.p. on the day of and 1d after MOG immunization. For clinical 
evaluation, mice were scored daily according to the following criteria: 0 - no clinical disease, 
1 - limp tail, 2 - hind limb weakness, 3 - hind limb paralysis, 4 - hind limb paralysis and partial 
front limb paralysis, 5 - moribund. Scores were assigned by an investigator blinded to the mouse 
genotypes. 
Histology 
For K/BxN serum transfer induced arthritis, mice were euthanized at the indicated time points 
and the paws were fixed in 10% formalin (Fisher). Decalcification, sectioning, paraffin 
embedding and hematoxylin and eosin (H&E) staining was performed by HistoTox Labs 
(Boulder, CO). Histology scoring was performed by an investigator blinded to the mouse 
genotypes. For inflammation scoring, the following criteria were used - 0, none; 1, mild; 2, 
moderate; 3, severe. For bone erosion scoring, the following criteria were used: 0, no bone 
erosions observed; 1, mild cortical bone erosion; 2, severe cortical bone erosion without the loss 
of bone integrity; 3, severe cortical bone erosion with the loss of cortical bone integrity and 
trabecular bone erosion. Cleaved caspase-3 staining was performed at the University of Virginia 
Biorepository and Tissue Research Facility. For RNA and protein isolation, the paws were snap 
frozen in liquid nitrogen at indicated time points and subjected to mechanical disruption using a 
tissue pulverizer (Spectrum Laboratories, Inc.). For EAE experiments, spinal cords were isolated 
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on day 26 after immunization, paraffin embedded and 4 µm sections were cut, stained with
Luxol Fast Blue and counterstained with hematoxylin following standard protocols. Extent of 
demyelination (loss of blue staining) in the white matter of the spinal cord was measured at 4 
different levels of the spinal cord. 
Flow cytometry of arthritic joints 
Mice were injected with the K/BxN serum on day 0 and day 2, as described above. On day 10, 
mice were euthanized and the skin removed from the hind paws. Ankle tendons were cut and the 
foot was detached from the tibia and placed in DMEM containing 20 units/ml of collagenase IV 
(Roche). The soft tissue was cut with a scalpel and the joints opened by gentle pulling of the foot 
bones. The paws were incubated for 2 hours at 37°C with periodic trituration. Liberated cells
were collected, strained though a 70 µm filter (Fisher), washed with DMEM, counted and
subjected to flow cytometry on Canto I flow cytometer using 7-aminoactinomycin D (7-AAD) to 
identify live cells, and anti-CD45 (eBioscience), anti-CD11b (eBioscience) and anti-Ly6G (clone 
1A8, BD Pharmingen) antibodies.  
Neutrophil isolation, stimulation and in vitro migration 
Femurs were removed from 6-8 week old mice, flushed with sterile serum-free a-MEM and
single cell suspensions were prepared using the 70 µm cell strainer. Cells were incubated with
anti-Ly6G antibody (clone 1A8, BD Pharmingen) and purified using the anti-PE MACS kit 
(Myltenyi), following manufacturer’s instructions. Purified neutrophils (Ly6G+) were seeded in 
96-well tissue culture U-bottom plates (106 cells per well) and stimulated with 100 ng/ml mouse
C5a (R and D Systems), 1-10 nM LTB4, 50 ng/ml PMA (Calbiochem) or 0.5-10 µg/ml LPS
(Escherichia coli 0111:B4, Sigma). Alternatively, high-binding 96-well plates (Greiner Bio-One)
were coated with 50 µg/ml of mouse IgG (Southern Biotech) in PBS for 16 hours at 4°C, washed
with PBS and purified neutrophils were seeded as above to induce FcgR-mediated neutrophil
stimulation. Cells were stimulated for 1 hour at 37°C, and the cells were then washed and stained
with antibodies specific for CD11b or CD88/C5aR1 (eBioscience) and subjected to flow
cytometry analysis on the Canto I (BD Bioscience) or the Attune Nxt (Thermo Fisher) flow
cytometer. In some experiments, supernatants from cells stimulated with IgG were collected by
centrifugation and removal of cell pellets and used for migration, as described below. For
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migration experiments, total bone marrow (2 x 106 cells per well) or purified Ly6G+ bone 
marrow cells (0.2-0.5 x 106 cells per well) were seeded in top chambers of 3 µm polycarbonate
Transwell plates (Corning) in 100 µl of HBSS (with calcium and magnesium, no phenol red,
Gibco) containing 1% bovine serum albumin (Roche). Bottom chambers contained 600 µl of
media without (control) or with the indicated concentrations of leukotriene B4 (LTB4, Tocris 
Bioscience) or CXCL1 (BioLegend), or undiluted supernatants from IgG-stimulated neutrophils. 
After 3 hours at 37°C, the cells in the bottom wells were collected and subjected to flow
cytometry analysis with counting beads (Spherotech, Inc.). The data is presented as percent of 
input cells. Alternatively, bone marrow neutrophils were isolated using the EasySep Mouse 
Neutrophil Enrichment Kit according to manufacturer’s instructions (StemCell Technologies, 
Vancouver, BC).  
Intravital imaging of neutrophil motility 
To visualize migration of neutrophils, intravital imaging was performed using FV1000-AOM 
multiphoton system (Olympus) equipped with a 25x NA1.05 water immersion objective. For 
two-photon excitation, a Mai-Tai HP Ti:Sa Deep See laser system (Spectra-Physics) was tuned 
to 900nm for imaging. Neutrophils labeled with CellTrackerTM Green CMFDA (Thermo Fisher 
Scientific Inc.) were intradermally injected into ear skin 2h before in vivo imaging. Mice were 
anesthetized by intraperitoneal injection of pentobarbital (Nembutal Sodium solution, Oak 
Pharmaceuticals, Inc., IL) and anesthetic condition was maintained using isoflurane. Hair of the 
mouse ear was removed using a commercial hair remover (Nair, Princeton, NJ). The anesthetized 
mice were laid in a ventral recumbent position on a custom-designed stage to expose the dorsal 
side of the ear pinna for imaging. MicroporeTM (3M health care, MN) tapes were placed to 
immobilize the ear skin.  Body temperature of the mice was controlled with heat pad and the ear 
immersed in a drop of glycerol/saline (40:60 v/v) and covered with a coverslip. Laser injury was 
induced by focusing the multiphoton laser tuned to 800 nm at a region within the ear dermis for 
5 seconds. To track and analyze the movements of the neutrophils, Volocity software 
(Improvision/Perkin-Elmer, Waltham, MA) and ImageJ (National Institutes of Health, Bethesda, 
MD) were used.
LPS challenge and bacterial killing 
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Elmo1+/+, Elmo1-/-, Elmo1fl/fl and MRP8-Cre/Elmo1fl/fl mice were anesthetized with isoflurane and 
20 µg of LPS was administered intranasally in a 50 µl volume. Eight hours later, mice were 
euthanized by anesthetic overdose. Post-euthanasia, an incision was made in the trachea and the 
bronchoalveolar spaces were lavaged with 750 - 1,000 µl of PBS. The bronchoalveolar lavage 
(BAL) fluid was subjected to flow cytometry using 7-AAD (BD Bioscience), anti-Ly6G-APC 
(eBioscience clone 1A8), anti-Ly6C-FITC (BD Biosciences clone AL-21), and anti-CD11b-PE-
Cy7 (eBioscience clone M1/70). Data was analyzed on the Canto I (BD) or the Attune Nxt 
(Thermo Fisher) flow cytometer. Counting beads (Spherotech ACBP-50-10) were used to 
calculate the absolute number of neutrophils in the BAL fluid. For neutrophil-mediated bacterial 
killing assays, neutrophils from Elmo1+/+ and Elmo1-/- mice were purified from the bone marrow 
using anti-Ly6G antibodies, as described above. Klebsiella pneumoniae strain 43816 (ATCC) 
was opsonized with heat inactivated, sterile FBS for 30 min at 37°C. Bacteria were washed twice 
and 200,000 bacteria were added to 100,000 purified neutrophils in a 96-well tissue culture plate 
for 1 hour at 37°C. In some wells, extracellular bacteria were killed by 1 µg/ml of gentamicin for 
10 min at 37°C. Number of surviving bacteria was determined by hypotonic lysis of neutrophils 
in cold water and serial dilution and culture on blood agar plates. 
 
Fecal-induced peritonitis (FIP) 
Fecal material was isolated from the caecum of donor wild type mice, resuspended in saline and 
passed through a 70µM strainer to remove large particles. Eight-week old male Elmo1+/+ and 
Elmo1-/- mice were injected intraperitoneally with an LD50 dosage of 1.5mg fecal content/g 
mouse weight 44,45. Core body temperature was measured using a MicroTherma 2T handheld 
thermometer (Braintree Scientific, TW2-107) and mice were scored for clinical signs according 
to a published murine sepsis severity scale 45. Some mice were euthanized 4 hours after FIP 
induction and peritoneal cells were flushed out with PBS containing 5% FBS. Cells were stained 
with Fixable Yellow (to identify viable cells, Thermo Fisher) and anti-Ly6G (eBioscience clone 
1A8) and subjected to flow cytometry on the Attune Nxt flow cytometer (Thermo Fisher). 
Human peripheral blood neutrophils 
Human neutrophils were kindly provided by Drs. Alison Criss and Asya Smirnov (University of 
Virginia). Neutrophils were collected from venous blood of de-identified healthy human donors 
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using dextran sedimentation followed by Ficoll gradient sedimentation and hypotonic lysis as 
described 127,128. Buffy coats were also collected and consist of the non-granulocytic cells 
collected from the Ficoll gradient. Genomic DNA from purified neutrophils was prepared using 
the MagMax DNA kit (Applied Biosystems) and the status of the ELMO1 rs11984075 SNP was 
determined using the TaqMan SNP genotyping assay (Applied Biosystems), following 
manufacturer’s instructions. For Transwell migration assays, 5 x 105 cells were seeded in top 
chambers of 3 µm polycarbonate Transwell plates in 100 µl of HBSS containing 1% bovine 
serum albumin, as described for mouse neutrophils. Bottom chambers contained 600 µl of 15 nM 
leukotriene B4. After 2 hours at 37°C, the cells in the bottom wells were collected and subjected 
to flow cytometry analysis with counting beads (Spherotech, Inc.), TO-PRO-3 iodide (to identify 
viable cells, Life Technologies), anti-CD16 (eBioscience) and anti-CD11b (BD Pharmingen) on 
Canto I flow cytometer (BD Bioscience). The data is presented as percent of input cells. 
 
Analysis of human HL-60 cells 
HL-60 cell line (ATCC) was grown in IMDM containing 20% FBS (Gemini Bio-Products) and 
1% penicillin/streptomycin/glutamine (Gemini Bio-Products). For differentiation into neutrophil-
like cells, HL-60 cells were treated with 1.25% DMSO (Sigma) for 4 days and then cultured 
without DMSO for 16h. For generating Elmo1 knockdown cells, HL-60 cells were transfected 
with 10 µg of human Elmo1 targeting or control shRNA pGFP-V-RS expression vectors 
(OriGene Technologies, Inc.) using electroporation using a 250 V, 25 ms pulse. After 24h, stably 
transfected cells were selected with 0.2 µg/ml puromycin (Gibco) and single cell cloning was 
performed by serial dilution. A total of three control and four Elmo1 shRNA clones were 
analyzed. Differentiated cells (1 x 105 cells per well) were seeded in top chambers of 3 µm 
polycarbonate Transwell plates in 100 µl of HBSS containing 1% bovine serum albumin, as 
described for neutrophils. Bottom chambers contained 600 µl of 100 nM leukotriene B4. After 1 
hour at 37°C, the cells in the bottom wells were collected and subjected to flow cytometry 
analysis, as described above. The data is presented as percent of input cells. 
Macrophage cultures 
For resident peritoneal macrophage preparation, peritoneal cells were flushed out with PBS 
containing 5% FBS. Collected cells were spun down, re-suspended in XVIVO-10 (Lonza) 
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containing 1% penicillin/streptomycin/glutamine and cultured on tissue culture dishes at 37°C 
and 5% carbon dioxide for 16h.  
Fibroblast-like synoviocytes 
Fibroblast-like synoviocytes (FLS) were prepared following established protocols 129. Briefly, 
skin was removed from the hind paws of euthanized 6-8 week old mice, the tendons of the ankles 
were cut, the paws dislodged from the tibias and placed into DMEM containing 1 mg/ml of 
collagenase IV, 10% FBS and 1% penicillin/streptomycin/glutamine. The joints of the foot were 
opened using gentle pulling of the foot bones. After a 1-hour incubation at 37°C, the liberated 
cells were collected, strained though a 70 µm filter (Fisher), and washed with DMEM containing 
10% FBS and 1% penicillin/streptomycin/glutamine. The cells were seeded into 10 cm tissue 
culture coated dishes and cultured at 37°C and 5 % CO2. Media was exchanged every three days 
and the cells were passaged using 0.25 % trypsin with 2.21 mM EDTA at near confluency. Cells 
were used for experiments after three passages. Culture purity was confirmed by flow cytometry 
analysis using anti-CD90.2, anti-VCAM1 and anti-CD11b antibodies (all from eBioscience). 
FLS had the spindle-like shape of fibroblasts and were CD90.2+VCAM1+CD11bneg. 
Microscopy 
All images were taken on an EVOS FL Auto (Fisher) and analyzed using the accompanying 
software. 
Quantitative RT-PCR 
Total RNA was isolated from cultured cells or pulverized paws using the RNA Easy kit (Qiagen) 
and cDNA prepared using the QuantiTect kit (Qiagen) according to manufacturer’s instructions. 
Quantitative gene expression for target and housekeeping genes was done using Taqman probes 
(Applied Biosystems) run on a StepOnePlus Real Time PCR System (Applied Biosystems).    
Immunoblotting 
Protein extracts were prepared from cultured cells or pulverized paws using RIPA lysis buffer 
with added protease inhibitors cocktail (Calbiochem), 1 mM phenylmethylsulfonyl fluoride 
(PMSF, Sigma) and 1 mM sodium orthovanadate (Sigma). Equal numbers of purified human 
neutrophils and buffy coat cells were directly lysed in SDS-PAGE sample buffer containing 
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protease inhibitors cocktail, PMSF, sodium orthovanadate and 100 mM dithiothreitol. Equal 
amounts of protein extract were loaded on TGX Precast gels (Bio-Rad), subjected to SDS-PAGE 
and transferred onto PVDF membranes using the Trans-Blot Turbo transfer system (Bio-Rad). 
Immunoblotting was performed using anti-ELMO1 rabbit polyclonal antibody	83, or anti-ERK2, 
anti-GAPDH or anti-beta-ACTIN-HRP as a loading control. Blots were exposed using the 
Western Lightning Plus ECL kit (Perkin Elmer) on the ChemiDoc Touch imaging system (Bio-
Rad). 
Proteomics and Mass Spectrometry 
Cells extracts were prepared in Triton X-100 lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 
10% glycerol, 0.2% Triton X-100, protease inhibitors cocktail (Calbiochem), 1 mM PMSF and 5 
mM sodium orthovanadate) for 1h on ice. Lysates were cleared by centrifugation for 10 min at 
13,200 rpm. ELMO1 was immunoprecipitated using the mouse anti-ELMO1 monoclonal 
antibody	 83, and immune complexes were washed and subjected to SDS-PAGE. The gels were 
stained with SimplyBlue Safe stain (Invitrogen) and destained with water. The gel bands were 
excised and frozen at -80 °C. After drying in a vacuum centrifuge, the gel bands were digested 
with 100 µL of trypsin (Promega) (20 µg/mL) at 37 °C for 16 h. The digested peptides were
extracted with 100 µL 70% acetonitrile, 5% formic acid in a sonication bath. Each peptide
sample was dried in a vacuum centrifuge and resuspended in 16 µL 0.1% TFA.  Each gel band
digest was analyzed by nanoflow liquid chromatography (LC) (Easy-nLC1000, ThermoFisher 
Scientific Inc.) coupled online with a an Orbitrap Fusion Lumos Tribrid MS (Thermo Fisher 
Scientific), samples were loaded on a C18 nano trap column, (Acclaim PepMap100 C18, 2 cm, 
nanoViper, Thermo Scientific) and resolved on a C18 Easy-Spray column (Acclaim PepMap 
RSLC C18, 2 µm, 100 Å, 75 µm x 500 mm, nanoViper, Thermo Scientific) with a linear gradient
of 2% mobile phase B (95 % acetonitrile with 0.1% formic acid) to 32% mobile phase B within 
60 min at a constant flow rate of 250 nL/min.  The C18 Easy-Spray column was heated at 50 °C 
during the analysis. The most intense molecular ions in each MS scan within 3s were 
sequentially selected for high-energy collisional dissociation (HCD) using a normalized collision 
energy of 35%. The mass spectra were acquired at the mass range of m/z 400-1600. The Easy-
Spray ion source (Thermo Scientific) capillary voltage and temperature were set at 1.9 kV and 
275 °C, respectively. Dynamic exclusion (30 s) was enabled during the MS/MS data acquisition 
Arandjelovic et al., Page No. 37 
to minimize redundant peptide fragmentation events. The RF lens was set to 30% during the MS 
analysis and both MS1 and MS2 spectra were collected in profile mode. Data was searched 
against a Swiss-Prot human protein database (http://www.uniprot.org/uniprot/) using Proteome 
Discoverer (v.2.1.1.21, Thermo Fisher Scientific) via Mascot (v. 2.5.1, Matrix Science Inc.) with 
the automatic decoy search option set followed by false-discovery rate (FDR) processing by 
Percolator. Data was searched with a precursor mass tolerance of 10 ppm and a fragment ion 
tolerance of 0.05 Da, a maximum of two tryptic miscleavages and dynamic modifications for 
oxidation (15.9949 Da) on methionine residues. Resulting peptide spectral matches (PSMs) were 
filtered using an FDR of ≤ 1% (Percolator q-value ≤ 0.01). For determination of cell type-
specific ELMO1 protein partners, only proteins that were present in all runs were analyzed. We 
calculated the normalized ratio of the Elmo1-/- spectral counts (Elmo1-/-/Elmo1+/++ Elmo1-/-). This 
calculation gives a value ranging from 0 to 1 with defined properties, where anything below 0.5 
indicates a protein present in Elmo1+/+ cells but lost in Elmo1-/- cells. We considered values at 
least one standard deviation and 2-fold decreased (e.g. values less than 0.36) to be meaningful 
ELMO1 binding partners. Cross-comparison of normalized ratios afforded us the ability to then 
cross-compare ELMO1 binding partners between cell types. 
IVIS Imaging 
At the indicated time points during K/BxN serum transfer induced arthritis, mice were 
anesthetized using isoflurane, injected intraperitoneally with 200 µl of 50 mg/ml luminol 
(Sigma) in sterile saline solution, and scanned/analyzed using the IVIS Spectrum (Perkin Elmer), 
following manufacturer’s instructions.  
RNA-Seq analysis 
Neutrophils were purified from the bone marrow using anti-Ly6G antibody, as described above. 
Peritoneal macrophages were prepared as described above. Total RNA was extracted and an 
mRNA library was prepared using Illumina TruSeq platform and followed by transcriptome 
sequencing using an Illumina NextSeq 500 cartridge. Cultures from four mice per group were 
sequenced. The statistical software package R (version 3.3.2) was used for all analyses. The 
Bioconductor package DESeq2 was used for differential gene expression analysis of RNA-seq 
data. Heatmaps were created using the R package gplots via the heatmap.2 package. R code used 
for bioinformatics analysis and heatmap generation is available upon request.  
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GWAS and experimental linkage analysis  
We searched publicly available genome-wide association studies of human disease for SNP by 
gene interactions. The list of curated databases of published studies that were used is 
summarized in Suppl. Table 1. Significance of a given SNP was determined in the original study. 
SNP by phenotype interactions were determined using the GWASdb SNP-phenotype association 
database. The data are plotted using a standardized p value as reported 130. For determination of 
experimental linkage, a search of curated databases such as the DISEASES experimental gene-
disease association database was performed (Suppl. Table 1). Significance of the experimental 
linkage association was determined via a previously established aggregated score 131-135. 
Statistical analysis.  
Statistical significance was determined using GraphPad Prism 5 or 6 using unpaired Student’s 
two-tailed t-test or two-way ANOVA. Variance was similar between groups. No 
inclusion/exclusion criteria were pre-established. A p-value of <0.05 (indicated by one asterisk), 
<0.01 (indicated by two asterisks), <0.001 (indicated by three asterisks), and <0.0001 (indicated 
by four asterisks) were considered significant.  
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Fig. 1. Engulfment protein ELMO1 contributes to inflammatory arthritis. 
a) Disease SNPs in Rheumatoid Arthritis discovered via search of the GWASdb SNP-disease
association database. The data are plotted using a standardized p value.
b) Expression of Elmo1 in total paw extracts from K/BxN mice by qRT-PCR. Each data point
represents one mouse.
c, d) ELMO1 protein level by immunoblotting and the quantification in total paw extracts from 
K/BxN mice and their healthy littermate controls. A representative of two independent 
experiments is shown. **p<0.01, Student’s t-test.
e, f) Schematic of the K/BxN serum induced arthritis model used (e), and immunoblotting for 
ELMO1 protein in the total paw extracts of Elmo1+/+ or Elmo1-/- mice either day 0 (Control) 
or day 10 after K/BxN serum injection. Bone marrow derived macrophages (BMDM) are 
shown as control. A representative of three independent experiments is shown.  
g) Paw swelling and clinical scores of Elmo1+/+ (n=5, white symbols), Elmo1+/- (n=7, black
symbols) and Elmo1-/- (n=5, green symbols) mice injected with 150 µl of K/BxN serum on
day 0 and 2. A representative experiment (n=3) is shown. *p<0.05, **p<0.01, ****p<0.0001,
Two-way ANOVA.
h) Hind paws of representative mice are shown on day 10 after K/BxN serum injection.
i) H&E staining of hind paws (see Methods) on day10 after K/BxN serum injection. Yellow
asterisks indicate areas of inflammatory cell infiltration. Each data point represents one
mouse. Scale bar = 1 mm. Data are composite of two independent experiments. ***p<0.001,
Student’s t-test.
j) Schematic representation of collagen induced arthritis (CIA) induction.
k) Immunoblot analysis of ELMO1 in the total paw extracts from healthy mice or on day 50
after CIA induction. A representative of two independent experiments is shown.
l) Collagen induced arthritis incidence is shown over the indicated time in Elmo1+/+-DBA
(n=13, white symbols), Elmo1+/--DBA (n=20, black symbols) and Elmo1-/--DBA (n=12,
green symbols) mice. Data compiled from three independent experiments is shown.
m) Paw swelling and clinical scores of Elmo1+/+-DBA (n=13, white symbols), Elmo1+/--DBA
(n=19, black symbols) and Elmo1-/--DBA (n=10, green symbols) mice with CIA. Data from
three independent experiments is shown. **p<0.01, ***p<0.001, Two-way ANOVA.
Figure 1. Engulfment protein ELMO1 contributes to inflammatory arthritis. 
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Fig. 2. ELMO1 expression in neutrophils regulates disease severity in arthritis. 
a) Hind paw ankle sections were stained with an antibody specific for cleaved caspase-3 (brown) 
and counter-stained with hematoxylin (blue) on day 10 after K/BxN serum injection. Apoptotic 
cells are indicated by arrows. Cleaved caspase-3 positive cells were counted in two different 
fields of view per section, and the average was multiplied by the inflammation score. Each 
symbol represents an individual animal. **p<0.01, Student’s t-test.
b) ELMO1 protein expression in macrophages (left panel) and in purified Ly6G+ bone marrow 
cells (Neutrophils, right panel). Representative of more than three independent 
experiments are shown.
c) Paw swelling and clinical scores of female Elmo1fl/fl alone or LysM-Cre alone (Control, n=9), or 
LysM-Cre/Elmo1fl/fl (n=9) mice injected with K/BxN serum on day 0 and 2. A composite of three 
independent experiments is shown. ****p<0.0001, Two-way ANOVA.
d) Representative hind paw ankle sections stained with hematoxylin and eosin on day 10 after 
K/BxN serum injection. Areas of inflammatory cell infiltration are indicated with yellow 
asterisks. Scale bar = 1 mm. *p<0.05, Student’s t-test.
e) Flow cytometry analysis of paws on day 10 after K/BxN serum injection. Cells in the 
singlet/7AADneg/CD45+ gate are shown. **p<0.01, Student’s t-test.
f) Elmo1fl/fl alone and CX3CR1-Cre alone (Control, n=4) or CX3CR1-Cre/Elmo1fl/fl (n=4) mice 
were injected with 150 µl of K/BxN serum on day 0 and 2 and the paw swelling and clinical 
scores measured as in Fig. 2c.
g) ELMO1 immunoblotting in the resident peritoneal macrophages of indicated mouse strains, as 
described in the Methods. Representative of three independent experiments is shown.
h) Elmo1fl/fl alone and MRP8-Cre alone (Control, n=8) or MRP8-Cre/Elmo1fl/fl (n=3) mice were 
injected with K/BxN serum on day 0 and 2, and the paw swelling and clinical scores measured as 
in Fig. 2c. A representative of three independent experiments is shown. ***p<0.001, 
****p<0.0001, Two-way ANOVA. All data are presented as mean +/- s.d.
i) Representative hind paw ankle sections stained with hematoxylin and eosin on day 10 after 
K/BxN serum injection. Areas of inflammatory cell infiltration are indicated with yellow 
asterisks. Scale bar = 1 mm. *p<0.05, Student’s t-test. 
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Fig. 3. Neutrophil-specific ELMO1 protein interactome includes regulators of chemotaxis 
linked to human arthritis. 
a) Schematic of the neutrophil and macrophage preparation for proteomic analyses. ELMO1-
associated proteins enriched in neutrophils (see Methods), when compared to macrophages, are
further indicated as neutrophil-specific.
b) Neutrophil-specific ELMO1 protein interaction network analyzed by STRING (string-db.org).
Colored nodes indicate query proteins (colors are assigned in arbitrary fashion). Filled nodes
represent proteins with known or predicted 3D structure. Known protein interactions are indicated
by the magenta (experimentally determined) and cyan (curated database indicated) colored lines.
Predicted protein interactions are indicated by green (gene neighborhood), olive (text-mining),
black (co-expression) and violet (protein homology) colored lines.
c) Human rheumatoid arthritis associated ELMO1 partners. Among the newly identified neutrophil-
specific ELMO1 protein partners, several have known linkages to human arthritis (for references,
please see Results section). Names of the proteins and genes (between parentheses) are shown.
Known biological functions of these proteins and their specific associations with arthritis are
listed. RA – rheumatoid arthritis; Tx – therapy.
d) Ly6G+ bone marrow cells were purified as described in Methods and cell migration toward LTB4
(1 nM) or CXCL1 (25 ng/ml) was evaluated. A representative of two experiments with two mice
per group is shown. *p<0.05, ***p<0.001, Student’s t-test.
e) Representative images of migration of Elmo1+/+ (n=2) and Elmo1-/- (n=3) neutrophils in vivo after
laser-induced injury (see Methods). Damaged area is indicated with yellow asterisks. Second
harmonic generation (gray), and neutrophils (green) are shown.
f) Track velocity, displacement rate and meandering index of Elmo1+/+ (n=2) and Elmo1-/- (n=3)
neutrophils before (-) and after (+) laser-induced injury. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001, Student’s t-test.
Figure 3. Neutrophil-specific ELMO1 protein interactome includes regulators of 
chemotaxis linked to human arthritis.  
Protein (Gene) Function (Reference) Association with human 
arthritis (Reference) 
CD88 (C5ar1) Inflammation (62) Increased levels in RA (72) 
CD11b (Itgam) Cell adhesion (64) Genetic association (77) 
Talin-1 (Tln1) Actin/cytoskeleton (51, 58) Proposed biomarker (76) 
Alpha-actinin-1 (Actn1) Actin/cytoskeleton (61) Increased levels in RA (74) 
MMP-9 (Mmp9) Chemotaxis (53) Genetic association (70) 
Galectin-3 (Lgals3) Chemotaxis, pleiotropic (54, 56, 63) Risk allele (73) 
CD45 (Ptprc) Phosphatase (55) Risk allele, Tx response (69) 
14-3-3 protein eta (Ywhah) Protein-protein interactions (52, 59, 67) Biomarker, autoantigen (75)
G6PD (G6pdx) Pentose-Phosphate Pathway (60) Genetic association (71)
Hexokinase-3 (Hk3) Glycolysis (66) Increased levels in RA (68)
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Fig. 4. ELMO1 promotes neutrophil migration to inflamed joints. 
a) Mice were injected with luminol on day 1 of K/BxN serum induced arthritis and imaged under
anesthesia using the IVIS Spectrum (see Methods). Yellow arrows point to the areas of neutrophil
recruitment in the paws. A representative of two independent experiments with two mice per
group is shown.
b) Schematic for cell surface CD11b up-regulation upon neutrophil stimulation.
c) Representative flow cytometry of neutrophil cell surface CD11b under resting (Ctrl) conditions or
after 1 hour of C5a-, LTB4- or IgG-stimulation.
d) CD11b geometric mean fluorescence index (MFI) in resting (Ctrl) and LTB4- or C5a-stimulated
neutrophils purified from Elmo1+/+ (black, n=4) and Elmo1-/- (green, n=4) mice. A representative
of six independent experiments with 2-4 mice per group is shown. ****p<0.0001, Student’s t-test.
e) C5aR1/CD88 geometric mean fluorescence index (MFI) in resting (Ctrl) and LTB4- or C5a-
stimulated neutrophils purified from Elmo1+/+ (black, n=4) and Elmo1-/- (green, n=4) mice (of
note, C5a-stimulated C5aR1/CD88 levels were also different from the resting condition with the
same level of statistic significance). ****p<0.0001, Student’s t-test.
f) Purified neutrophil migration towards LTB4 (1 nM) in the absence (Control, black symbols) or
presence of CD11b neutralizing antibody (CD11b Ab, 10 µg/ml, open symbols). Comparison to
Elmo1-/- neutrophils (green symbols) is shown. The data are composite of two independent
experiments and each symbol represents an individual animal. *p<0.05, **p<0.01, Student’s t-
test.
g) CD11b geometric mean fluorescence index (MFI) in resting (Ctrl) and PMA (50 ng/ml, left panel)
or LPS (right panel) stimulated neutrophils purified from Elmo1+/+ (black, n=3-4) and Elmo1-/-
(green, n=3) mice.
h) CD11b geometric mean fluorescence index (MFI) in resting (Ctrl) or IgG (plate-bound)
stimulated neutrophils purified from Elmo1+/+ (black) and Elmo1-/- (green) mice. A representative
of three independent experiments with 2-3 mice per group is shown.
i) Purified neutrophil migration towards supernatants from IgG-stimulated Elmo1+/+ (black) and
Elmo1-/- (green) neutrophils. Migration towards LTB4 (10 nM, checkered) was used as a positive
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control and vehicle control (Ctrl, white) as a negative control. A representative of three 
independent experiments with 2-3 mice per stimulation is shown. 
) Schematic of the K/BxN serum transfer arthritis induction and treatment with tamoxifen to induce 
deletion of Elmo1 during ongoing arthritis.
) Clinical scores of male and female Ubc-CreERt2/Elmo1fl/fl (n=9 for males, n=7 for females, green 
symbols) and littermate control (n=12 for males, n=10 for females, black symbols) mice with 
K/BxN serum transfer induced arthritis. Data compiled from three independent experiments is 
shown. ****p<0.0001  a  .
) ELMO1 protein level in the peritoneal (males, top panels) or bone marrow (females, bottom 
panels) cells from tamoxifen-treated Ubc-CreERt2/Elmo1fl/fl (+) and littermate control (-) mice with 
K/BxN serum transfer induced arthritis (day 20 after arthritis induction). All data are presented as 
mean +/- s.d. 
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Fig. 5. Elmo1 function regulates cell type-specific transcriptional programs.
a) Schematic for the preparation of neutrophils and macrophages for RNA isolation and RNA-seq 
experiments, as described in the Methods.
b) Venn diagram of Elmo1-regulated transcripts in neutrophils and macrophages. Examples of 
shared and cell-type specific Elmo1-regulated transcripts are shown. Compared to Elmo1+/+ cells, 
transcripts that are down-regulated in Elmo1-/- cells are indicated in blue text, and transcripts that 
are up-regulated are shown in red text.
c) Heatmap and list of Elmo1-regulated neutrophil-specific transcripts that have associations with 
human Rheumatoid Arthritis (RA). SNP – single nucleotide polymorphism; Tx – therapy.
d) Quantitative PCR validation of some of the neutrophil-specific arthritis-associated genes in c). 
Each symbol represents a mouse. All data are presented as mean +/- s.d. *p<0.05, **p<0.01, 
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Fig. 6. ELMO1 rs11984075 SNP promotes migration of human neutrophils.
a) Unique SNPs in ELMO1 associated with indicated diseases. SNPs are plotted as the negative log 
of the p value significance by chromosomal position.
b) Allelic discrimination plot of ELMO1 wild type and rs11984075 SNP alleles in the genomic 
DNA from healthy human donors in duplicates. Two donors were heterozygous for the ELMO1 
rs11984075 (blue symbols). Two wild type (WT, black symbols) donors are shown. No DNA 
controls are shown in gray.
c) Immunoblotting of ELMO1 protein expression in peripheral blood neutrophils from human 
donors homozygous for the ELMO1 wild type (WT/WT) allele or heterozygous for the ELMO1 
rs11984075 SNP (WT/rs11984075) allele. Protein abundance was normalized to actin levels and 
presented as fold-WT. Representative of two independent experiments is shown.
d) Transwell migration of purified human peripheral blood neutrophils to LTB4 (15 nM), as 
described in Methods. Representative of two independent experiments. Data are presented as 
mean +/- s.d. ***p<0.001, Student’s t-test.
e) Representative flow cytometry plot of cell surface L-selectin/CD62L levels on purified human 
peripheral blood neutrophils from healthy donors without (Control, WT, black line) or with 
heterozygous ELMO1 rs11984075 mutation (blue line). FMO, fluorescence minus one. 
Representative of two independent experiments.
f) Representative flow cytometry plots of CD62L levels on the surface of Ly6G+ peripheral blood 
neutrophils (left panel) and the quantification of the mean fluorescence index (MFI, right panel). 
**p<0.01, ***p<0.001, Student’s t-test.
g) Representative flow cytometry plots of CD62L levels on the surface of Ly6G+ neutrophils in the 
bone marrow.
h) ELMO1 protein expression in HL-60 cells stably transfected with non-targeting control (Ctrl) or 
ELMO1 targeting shRNA. Actin protein expression is used as a loading control. A representative 
of three or more independent experiments is shown. A total of three control and four ELMO1 
targeting shRNA single cell clones were analyzed.
i) igration to LTB4 (100 nM) was evaluated in HL-60 clones expressing  control or ELMO1 
targeting shRNA as described in the Methods. A representative of three independent 
experiments is shown. A total of three control and four ELMO1 targeting shRNA single cell 
clones were analyzed. Mean +/- s.d. ***p<0.001  de  e . 
Figure 6. Elmo1 function regulates migration in human neutrophils. 
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Supplementary Figure 1. Loss of ELMO1, but not BAI1, reduces disease severity in arthritis. 	
a) Mice with spontaneous arthritis (K/BxN) or their healthy littermates were used to analyze 
engulfment machinery expression in isolated paws 
b) Expression of apoptotic cell clearance components genes in total paw extracts from K/BxN mice 
by qRT-PCR. Each data point represents one mouse. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001, Student’s t-test. 
c) Incidence of CIA in male Elmo1+/+-DBA (n=3, white symbols), Elmo1+/--DBA (n=12, black 
symbols) and Elmo1-/--DBA (n=5, green symbols).  
d) Swelling of the paws was measured (left panel) and clinical scores (right panel) assigned as 
described in the Methods and are shown for animals presenting clinical signs of disease in c). 
Data shown are composite of two independent experiments. All data are presented as mean +/- 
s.d. *p<0.05, Two-way ANOVA. 
e) Incidence of CIA in female Elmo1+/+-DBA (n=5, white symbols), Elmo1+/--DBA (n=8, black 
symbols) and Elmo1-/--DBA (n=5, green symbols) (top panel).  
f) Swelling of the paws was measured (left panel) and clinical scores (right panel) assigned as 
described in the Methods and are shown for animals presenting clinical signs of disease in e). 
Data shown are composite of two independent experiments. All data are presented as mean +/- 
s.d. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, Two-way ANOVA. 
g) Elmo1, Elmo2 and Elmo3 expression was analyzed by quantitative RT-PCR in the total paw 
extracts of Elmo1+/- (black symbols) and Elmo1-/- (green symbols) mice on day 10 after K/BxN 
serum injection. Each symbol represents an individual animal. ***p<0.001, Student’s t-test. 
h) Schematic of BAI1 binding to ELMO1-DOCK2, leading to the activation of GTPase RAC1. 
i) Paw swelling and clinical scores of BAI1+/+ (n=4, black symbols) and BAI1-/- mice (n=11, blue 
symbols) injected with 150 µl of K/BxN serum on day 0. Data shown are composite of two 
independent experiments.  
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Supplementary Figure 2. ELMO1 expression in neutrophils, but not macrophages, contributes 
to disease severity in K/BxN serum induced arthritis. 	
a) Immunoblot analysis of ELMO1 protein expression in resident peritoneal macrophages from 
indicated mice. A representative of two independent experiments is shown. 
b) Paw swelling and clinical scores of wild type (n=4, black symbols) and LysM-Cre (n=3, blue 
symbols) mice injected with 150 µl of K/BxN serum on day 0 and 2. A representative of two 
independent experiments is shown. 
c) Paw swelling and clinical scores of Elmo1fl/fl (Control, n=7) or LysM-Cre/Elmo1fl/fl (n=5) mice 
injected with 150 µl of K/BxN serum on day 0 and 2. 
d) Flow cytometry analysis of paws from indicated mice on day 10 after K/BxN serum injection. 
Cells in the singlet gate are shown.  
e) Paw swelling and clinical scores of Elmo1fl/fl (Control, n=5) or CX3CR1-Cre/Elmo1fl/fl (n=5) mice 
injected with 150 µl of K/BxN serum on day 0 and 2. 
f) Representative hind paw ankle sections stained with hematoxylin and eosin on day 10 after 
K/BxN serum injection (left panels). Areas of inflammatory cell infiltration are indicated with 
yellow asterisks. Scale bar = 1 mm. Quantification of inflammation (right panel) indicates no 
difference between Elmo1fl/fl and CX3CR1-Cre/Elmo1fl/fl mice. 
g) Paw swelling and clinical scores of Elmo1fl/fl (Control, n=6) or MRP8-Cre/Elmo1fl/fl (n=3) mice 
injected with 150 µl of K/BxN serum on day 0 and 2. 
h) Immunoblot analysis of ELMO1 protein expression in the Ly6G+ cells purified from the bone 
marrow of indicated mouse strains, as described in the Methods. A representative of three 
independent experiments is shown. 
i) Paw swelling and clinical scores of wild type (n=8, black symbols) and MRP8-Cre (n=3, 
magenta symbols) mice were injected with 150 µl of K/BxN serum on day 0 and 2. 
j) Immunoblotting of ELMO1 protein expression in neutrophils purified from the bone marrow and 
fibroblast like synoviocytes (FLS) from the indicated strains of mice. 
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Supplementary Figure 3. Bacterial challenge response and EAE are not changed in Elmo1-/-
mice.  
	
a) Elmo1+/+, Elmo1-/-, Elmo1fl/fl and MRP8-Cre/Elmo1fl/fl mice were challenged with LPS 
administered intranasally as described in the Methods and mobilization of neutrophils was 
analyzed 8 hours later by flow cytometry of cells in the BAL.  
b) Quantification of 7-AAD-CD11b+Ly6C+Ly6G+ neutrophils in the BAL of mice in a). Each 
symbol represents an animal. For Elmo1+/+ and Elmo1-/- mice, a representative of two 
independent experiments is shown. 
c) Elmo1+/+ (n=18) and Elmo1-/- (n=19) mice were injected with fecal contents (1.5 mg/g) 
intraperitoneally to induce fecal-induced peritonitis (FIP) and disease parameters were monitored 
as described in Methods. 
d) Number of Ly6G+ neutrophils in the peritoneum 4 hours post FIP induction. Each symbol 
represents an animal. 
e) Temperature of mice in c). 
f) Clinical scores of mice in c) were measured as described in Methods. 
g) Survival curves of mice in c). All mice alive at 72 hours post FIP induction exhibited complete 
recovery. 
h) Purified neutrophils from Elmo1+/+ and Elmo1-/- mice were incubated with Klebsiella 
pneumoniae at a 1:2 ratio for 1 hour, as described in the Methods, and bacterial killing was 
analyzed. Each symbol represents neutrophils from an individual animal.  
i) Elmo1+/- (n=8, black symbols) and Elmo1-/- (n=8, green symbols) mice were immunized to 
induce EAE and disease was scored over the indicated time as described in the Methods. A 
representative of three independent experiments is shown.  
j) Luxol Fast Blue staining of the spinal cords on day 26 after EAE induction (left panel). 
Demyelination was scored at four different levels of the spinal cord and composite result is 
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Supplementary Figure 4. Elmo1 deletion in neutrophils inhibits neutrophil migration.  
 	
a) Total bone marrow cells were purified as described in the Methods, and cell migration toward 
the indicated concentrations of LTB4 or CXCL1 was evaluated after 3 hours at 37°C by flow 
cytometry. Two mice per group were analyzed. *p<0.05, ***p<0.001, Student’s t-test. 
b) Transcript levels of the LTB4 receptor Blt1 are analyzed by qPCR. Representative of two 
independent experiments. 
c) Flow cytometry analysis of cell surface levels of CXCR2 on Ly6G+ neutrophils in the blood (top 
panels) and the bone marrow (bottom panels) of Elmo1+/+ and Elmo1-/- mice. MFI, mean 
fluorescence index. FMO, fluorescence minus one. Representative of two independent 
experiments. 
d) Flow cytometry analysis of cell surface levels of FcgRIII and FcgRIV on CD11b+Ly6G+ 
neutrophils in the blood (top panels) and the bone marrow (bottom panels) of Elmo1+/+ and 
Elmo1-/- mice. Representative of two independent experiments. 
e) Immunoblotting of FcgRI protein expression in Ly6G+ neutrophils purified from the bone 
marrow of Elmo1+/+ and Elmo1-/- mice. Representative of two independent experiments. 
f) Immunoblotting of Syk protein expression in Ly6G+ neutrophils purified from the bone marrow 
of Elmo1+/+ and Elmo1-/- mice. Representative of two independent experiments. 
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Supplementary Figure 5. Inducible deletion of Elmo1 in ongoing arthritis. 
 
a) Paw swelling of male and female Ubc-CreERt2/Elmo1fl/fl (n=9 for males, n=7 for females, green 
symbols) and littermate control (n=12 for males, n=10 for females, black symbols) mice with 
K/BxN serum transfer induced arthritis and tamoxifen administration (arrows). Data compiled 
from three independent experiments is shown. ****p<0.0001, Two-way ANOVA. 
b) Paw swelling (left panel) and clinical scores (right panel) of Elmo1fl/fl (control, n=5) and Ubc-
CreERt2/Elmo1fl/fl (n=3) mice with K/BxN serum transfer induced arthritis without tamoxifen 
administration. 
c) Schematic of the K/BxN serum transfer arthritis induction and treatment with tamoxifen to 
induce deletion of Elmo1 during ongoing arthritis. 
d) Paw swelling of male Ubc-CreERt2/Elmo1fl/fl (n=3, green symbols) and littermate control (n=6, 
black symbols) mice with K/BxN serum transfer induced arthritis and tamoxifen administration 
(arrows).  
e) ELMO1 protein expression in human peripheral blood neutrophils (duplicates are shown) and 
buffy coat cells from two different donors (1 and 2). ERK protein expression is used as a loading 
control. A representative of more than three independent experiments is shown. 
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Adenylyl cyclase-associated protein 1 Cap1 
SUN domain-containing protein 2 Sun2 
Receptor-type tyrosine-protein phosphatase C Ptprc 
ATP synthase subunit beta, mitochondrial Atp5b 
Transitional endoplasmic reticulum ATPase Vcp 
Glycogen phosphorylase, liver form Pygl 
Integrin alpha-M Itgam 
Matrix metalloproteinase-9 Mmp9 
C5a anaphylatoxin chemotactic receptor 1 C5ar1 
Galectin-3 Lgals3 
Tubulin beta-4B chain Tubb4b 
Tubulin alpha-1B chain Tuba1b 
Tubulin alpha-4A chain Tuba4a 
Aldehyde dehydrogenase, mitochondrial Aldh2 
Galactocerebrosidase Galc 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 
Hexokinase-3 Hk3 
Leukocyte immunoglobulin-like receptor subfamily B member 3 Lilrb3 
Ferritin light chain 1 Ftl1 
14-3-3 protein theta Ywhaq 
14-3-3 protein eta Ywhah 
Hypoxia up-regulated protein 1 Hyou1 
Hemoglobin subunit beta-1 Hbb-b1 
Hemoglobin subunit alpha Hba 
Glucose-6-phosphate 1-dehydrogenase X (G6PD) G6pdx  
40S ribosomal protein S8 Rps8 
Cytochrome b-245 heavy chain (Nox2, gp91phox) Cybb 
Cytoskeleton-associated protein 4 Ckap4 




Shared Fold	Change		(log2) Neutrophil-specific	genes	regulated	by	Elmo1 Macrophage-specific	genes	regulated	by	Elmo1
Symbol Neutrophils Macrophages Symbol Fold	Change		(log2) Symbol Fold	Change		(log2)
Elmo1 2.88046419 2.355475856 Pmaip1 -0.6287105 Il9r -0.9410805
Aoah 0.91585074 0.56933025 Dip2c -0.5581848 Igkv9-120 -0.6246305
Ero1lb 1.37228266 0.852185623 Lars2 -0.5143661 Cxcl1 -0.5262091
Gpr137b -1.9799561 -0.927126864 Gpr132 -0.4988293 Camk2b -0.4889724
Gpr137b-ps 2.61727206 2.992377917 H2-Q7 -0.4852265 Igkv4-59 -0.4280269
Hist1h2bc 0.39396578 0.742381795 H3f3b -0.4729891 Ighv8-8 -0.4244122
Zkscan8 -0.5716376 -0.355224675 Impact -0.4575106 Ighv14-3 -0.4116772
Stard3nl -0.3964277 0.430240833 Gm23935 -0.4544578 Ighv10-1 -0.409747
Ggps1 -0.5492517 0.460340538 Sertad3 -0.4461594 Igkv16-104 -0.3948993
Hist1h4i -0.6966969 0.435461088 CT010467.1 -0.43997 Amigo1 -0.3676841
H2-Q8 -0.4363432 Phldb1 -0.3651322
Thbs1 -0.4180925 Scand1 -0.2930737
Clec7a -0.4010477 Syk -0.1552282
Chrm3 -0.3822215 Mvd 0.15954244
Mir22hg -0.3797558 Snx6 0.17639781
Cirbp -0.3638295 Stard4 0.1813722
Wsb1 -0.363417 Sc5d 0.22302841
Btg1 -0.3566311 Twf1 0.22599258
Slc3a2 -0.3360407 Fgd4 0.2379303
Srgn -0.3357759 Zak 0.2508524
Lgals8 -0.3348986 Dhcr7 0.25397103
Dtd1 -0.3347969 Ndufaf7 0.25793667
Pdcd5 -0.3175303 Nsdhl 0.26838356
Frat2 -0.3153359 Pbx1 0.26915745
Pgrmc1 -0.312537 Mmab 0.28948315
Pik3c3 -0.3072427 Hmgcs1 0.30509134
Plekha1 -0.3030843 Igkv12-89 0.30760871
Metrnl -0.2997594 Idi1 0.31024232
2410006H16Rik-0.2961188 Lss 0.31529684
Tnfaip3 -0.2948153 Tagap 0.31623132
Vnn3 -0.2935827 Fcor 0.40977711
Tspan13 -0.291365 Ifitm6 0.42575208
Fundc2 -0.2880764 Lipn 0.44284386
H2-Q10 -0.2775205 Cfp 0.45686245
Gm9733 -0.2687127 Hfe 0.61228442
Eif1 -0.2601325 Akr1c12 0.69589039
Cd84 -0.2568044 Akr1e1 0.79768911
Tob1 -0.255246
N4bp2l1 -0.2478644
Klra2 -0.2415313
Amica1 -0.2381203
Smim3 -0.2328521
Fcho2 -0.2104856
Vamp3 -0.2098115
Rps14 -0.204736
Slc44a1 -0.1994221
Arg2 -0.1940317
Hgsnat -0.1929145
Cd24a -0.182328
Gng2 -0.180254
Smim7 -0.1614396
Dazap2 -0.1429415
Bmx -0.1189023
Atp8b4 0.16688062
Ankfy1 0.16893629
Ptpn9 0.18710878
N4bp1 0.19170722
Mbnl2 0.19926456
Pfkfb3 0.20030507
Numb 0.20121481
Gabpb2 0.20128893
Ubp1 0.2013883
Elovl1 0.20160334
Brd3 0.20470841
Ctr9 0.20633207
Suv420h1 0.21161419
Ncoa3 0.21343811
Atad2b 0.21586325
Stard8 0.21598731
Arhgap27 0.21810428
Ncoa1 0.21994267
Eya3 0.2206874
Clip1 0.22335287
Kidins220 0.22676513
Arhgef11 0.22962916
Myo9b 0.23404124
Tbc1d1 0.23689488
Arid2 0.23731034
Utrn 0.23740368
Myo18a 0.23949916
Tbc1d2 0.24154777
Ncor1 0.24221615
Rbbp6 0.24260904
Arhgef18 0.24380725
Tcf20 0.24806281
Fanca 0.24868013
Jmjd1c 0.25009531
Fkbp5 0.25150588
Upf2 0.25199966
B430306N03Rik0.25283563
Smarcc2 0.25383235
Aff1 0.25537644
Chdh 0.2574246
Nhsl2 0.25811997
Hcfc1 0.2588155
Tirap 0.25908799
Card6 0.25971648
Rnf24 0.25986769
C2cd3 0.26080834
Ston2 0.26138725
Tnrc18 0.26286031
Usf3 0.2644112
Lhfpl2 0.26698062
Arid1a 0.26721421
Rap1gap2 0.26752142
6430548M08Rik0.26759788
Mlxip 0.26792125
Tet3 0.26864073
Akna 0.27174232
Pag1 0.27209798
Sipa1l2 0.27230213
Maml1 0.27264292
Cep350 0.27338775
Smarca4 0.27447055
Ccdc88b 0.27520868
Golga3 0.2766627
Bdp1 0.281903
Hivep1 0.28374459
Mrpl49 0.28603615
Myo5a 0.28652454
Sh2b3 0.28660663
Kmt2c 0.28716554
Cdan1 0.28740851
Mkl1 0.28833755
Tnrc6c 0.28957016
Myo1d 0.29027612
Iqsec1 0.29162835
Baz2a 0.29294464
Prrc2a 0.29445331
Nin 0.2958455
Stk10 0.29748554
Fry 0.2995433
Bptf 0.30089401
Rhbdf2 0.30124038
Zmiz1 0.30160412
Anks1 0.30213688
Dhrs9 0.30411591
Trip11 0.30469741
Inhba 0.30602791
A430078G23Rik0.30692113
Kat6a 0.30775459
Trim16 0.30781937
Yeats2 0.30813637
Dopey2 0.3091297
Golga4 0.31263196
Cflar 0.31271921
Magi3 0.31356419
Kmt2d 0.31465308
Ep300 0.31892093
Ncoa6 0.32318875
Kmt2a 0.3232111
Rrbp1 0.32330835
Cep250 0.32355772
Myh9 0.32534412
Prrc2c 0.326548
Zfp609 0.32962314
Clasp1 0.33104181
Plau 0.33178856
Cdk12 0.3340357
Erc1 0.33440228
Prrc2b 0.33608834
Dcp1a 0.33676443
Ppp1r10 0.33799375
Zfyve26 0.33903101
Setd1b 0.33908818
Tor4a 0.34174994
Golgb1 0.34257573
Rreb1 0.34299995
Kif21b 0.34347578
Plec 0.35394367
Nuak2 0.35804294
Gpr84 0.35936575
Dock5 0.36174605
Ap5b1 0.36196453
Spen 0.36730986
Lmo1 0.36797468
Ankrd11 0.37143906
Camkk1 0.39242286
Rasa2 0.40345356
Bcorl1 0.40379523
Irf1 0.40903726
Ccdc88c 0.43062067
C130026I21Rik0.44820577
Zfp142 0.45713544
